open access
Gynecomastia in multi-drug resistant tuberculosis — ethionamide the villain
Affiliations- Government Medical College and Hospital, Miraj, Maharashtra, India
- Government Medical College, Patiala, Punjab, India
open access
Abstract
Abstract
Keywords
gyanecomastia; adverse drug reaction
About this articleTitle
Gynecomastia in multi-drug resistant tuberculosis — ethionamide the villain
Journal
Advances in Respiratory Medicine
Issue
Article type
Clinical vignette
Pages
162-163
Published online
2020-04-30
DOI
10.5603/ARM.2020.0093
Pubmed
Bibliographic record
Adv Respir Med 2020;88(2):162-163.
Keywords
gyanecomastia
adverse drug reaction
Authors
Kunal Deokar
Abdul Latif Shaikh
Gopal Chawla
References (5)- 1. The use of the WHO-UMC system for standardized case causality assessment. Accessed from: www.who.int/medicines/areas/quality_safety/safety_efficacy/WHOcausality_assessment.pdf. [Access: 20.05.2019].
- Deepinder F, Braunstein GD. Drug-induced gynecomastia: an evidence-based review. Expert Opin Drug Saf. 2012; 11(5): 779–795.
- Dixit R, George J, Sharma AK, et al. Ethionamide-induced gynecomastia. J Pharmacol Pharmacother. 2012; 3(2): 196–199.
- Sharma PK, Bansal R. Gynecomastia caused by ethionamide. Indian J Pharmacol. 2012; 44(5): 654–655.
- Tiberi S, Pontali E, Tadolini M, et al. Challenging MDR-TB clinical problems. The case for a new Global TB Consilium supporting the compassionate use of new anti-TB drugs. Int J Infect Dis. 2019; 80S: S68–S72.